Prognostic value of CD8-positive tumor stroma-infiltrating lymphocytes and PD-L1 positive tumor cells at initial biopsy in patients with locally advanced NSCLC treated with chemoradiotherapy

被引:0
|
作者
Gennen, K. [1 ]
Kaesmann, L. [1 ]
Eze, C. [1 ]
Dantes, M. [1 ]
Roengvoraphoj, O. [1 ]
Taugner, J. [1 ]
Neumann, J. [2 ]
Tufman, A. [3 ]
Orth, M. [1 ]
Reu, S. [4 ]
Belka, C. [1 ]
Manapov, F. [1 ]
机构
[1] LMU Klinikum Univ Munchen, Radiat Oncol, Munich, Germany
[2] LMU Klinikum Univ Munchen, Pathol, Munich, Germany
[3] LMU Klinikum Univ Munchen, Munich, Germany
[4] Univ Hosp Wurzburg, Pathol, Wurzburg, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
33P
引用
收藏
页码:11 / 11
页数:1
相关论文
共 50 条
  • [1] Prognostic Significance of CD8 positive Stromal Tumor Infiltrating Lymphocytes (sTIL) and PD-L1 positive Tumor Cells in initial Biopsy in locally advanced NSCLC after Radio Chemotherapy
    Gennen, K.
    Kaesmann, L.
    Eze, C.
    Dantes, M.
    Roengvoraphoj, O.
    Taugner, J.
    Neumann, J.
    Tufman, A.
    Orth, M.
    Reu, S.
    Belka, C.
    Manapov, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S143 - S144
  • [2] Clinical Significance of PD-L1 Expression and CD8-Positive Tumor-Infiltrating Lymphocytes in Patients with Cavitary Lung Adenocarcinoma
    Liu, Jiangyong
    Gu, Mingming
    Xue, Yang
    Wang, Qiong
    Ren, Yong
    Huang, Wencai
    ONCOLOGIE, 2021, 23 (03) : 439 - 452
  • [3] Prognostic value of PD-L1 expression in locally advanced NSCLC treated with chemoradiotherapy
    Gennen, K.
    Kaesmann, L.
    Eze, C.
    Dantes, M.
    Roengvoraphoj, O.
    Taugner, J.
    Neumann, J.
    Mille, E.
    Tufman, A.
    Huber, R. M.
    Orth, M.
    Reu, S.
    Niyazi, M.
    Belka, C.
    Manapov, F.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S403 - S403
  • [4] Prognostic value of tumor microenvironment based on PD-L1 expression and CD8+TILs density in locally advanced NSCLC treated with concurrent chemoradiotherapy
    Kaesmann, Lukas
    Gennen, Kathrin
    Taugner, Julian
    Eze, Chukwuka
    Karin, Monika
    Roengvoraphoj, Olarn
    Neumann, Jens
    Tufman, Amanda
    Orth, Michael
    Reu, Simone
    Belka, Claus
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [5] Prognostic Effect of CD8-positive Tumor-infiltrating Lymphocytes and PD-L1-expressing Cells in Salivary Gland Carcinomas
    Kesar, N.
    Winkelmann, R.
    Oppermann, J.
    Ghanaati, S.
    Martin, D.
    Neumayer, T.
    Balster, S.
    Roedel, C.
    Roedel, F.
    von der Gruen, J.
    Balermpas, P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S51 - S51
  • [6] The induction of PD-L1 positive immune cells and CD8-positive T lymphocytes by neoadjuvant chemoradiotherapy for rectal cancer
    Yamashita, Kimihiro
    Nakagawa, Akio
    Tanaka, Tomoko
    Arimoto, Akira
    Fukuoka, Eiji
    Sugita, Yutaka
    Mukohyama, Junko
    Dalerba, Piero
    Hasegawa, Hiroshi
    Matsuda, Takeru
    Suzuki, Satoshi
    Kakeji, Yoshihiro
    CANCER RESEARCH, 2018, 78 (13)
  • [7] Prognostic implication of CD8-positive tumor-infiltrating lymphocytes of rectal cancer
    Koizumi, K
    Shinto, E
    Ueno, H
    Hashiguchi, Y
    Matsubara, O
    Mochizuki, H
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S108 - S108
  • [8] PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC
    Ameratunga, Malaka
    Asadi, Khashayar
    Lin, Xihui
    Walkiewicz, Marzena
    Murone, Carmel
    Knight, Simon
    Mitchell, Paul
    Boutros, Paul
    John, Thomas
    PLOS ONE, 2016, 11 (04):
  • [9] Prognostic impact of CD8-positive tumour-infiltrating lymphocytes and PD-L1 expression in salivary gland cancer
    Kesar, Nikolina
    Winkelmann, Ria
    Oppermann, Julius
    Ghanaati, Shahram
    Martin, Daniel
    Neumayer, Thomas
    Balster, Sven
    Roedel, Claus
    Roedel, Franz
    von der Gruen, Jens
    Balermpas, Panagiotis
    ORAL ONCOLOGY, 2020, 111
  • [10] Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients
    Koh, Jiwon
    Ock, Chan-Young
    Kim, Jin Won
    Nam, Soo Kyung
    Kwak, Yoonjin
    Yun, Sumi
    Ahn, Sang-Hoon
    Park, Do Joong
    Kim, Hyung-Ho
    Kim, Woo Ho
    Lee, Hye Seung
    ONCOTARGET, 2017, 8 (16) : 26356 - 26367